Stockscreener 앱 받기
113.60
1.43%
1.60
시간 외 거래:
113.60
전일 마감가:
$112.00
열려 있는:
$112.03
하루 거래량:
458.80K
Relative Volume:
0.56
시가총액:
$13.83B
수익:
$2.72B
순이익/손실:
$254.30M
주가수익비율:
54.97
EPS:
2.0665
순현금흐름:
$564.37M
1주 성능:
+1.44%
1개월 성능:
-1.23%
6개월 성능:
+10.76%
1년 성능:
+8.17%
1일 변동 폭
$110.72
$113.84
1주일 범위
$109.39
$113.84
52주 변동 폭
$97.31
$129.50
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
RVTY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
113.60 | 13.83B | 2.72B | 254.30M | 564.37M | 2.0665 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - MSN
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Revvity (FRA:PKN) Float Percentage Of Total Shares Outstanding : 75.15% (As of Dec. 30, 2024) - GuruFocus.com
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
(RVTY) Proactive Strategies - Stock Traders Daily
Is Revvity Stock Underperforming the S&P 500? - Nasdaq
Is Revvity Stock Underperforming The S&P 500? - Barchart
Revvity Inc. stock rises Tuesday, still underperforms market - MarketWatch
Revvity, Inc. (NYSE:RVTY) Receives $132.47 Consensus Target Price from Brokerages - MarketBeat
China Neurogenomics Market Research 2024-2031, Profiles of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, MGI Tech, Agilent, Revvity, Qiagen, Pacific Biosciences, Danaher, Oxford NanoporeResearchAndMarkets.com - WICZ
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
How To YieldBoost Revvity To 12.8% Using Options - Nasdaq
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching - Simply Wall St
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Scale Biosciences and Revvity’s BioLegend launch high parameter protein profiling of single cells - SelectScience
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity CEO to Present Strategic Vision at J.P. Morgan Healthcare Conference 2025 - StockTitan
Jane Street Group LLC Sells 164,156 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Trend Tracker for (RVTY) - Stock Traders Daily
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Safe Biopharma: Revvity’s Recurring Revenues And Diagnostics (NYSE:RVTY) - Seeking Alpha
Tidal Investments LLC Buys 50,666 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity, Inc. (NYSE:RVTY) Shares Purchased by Geode Capital Management LLC - MarketBeat
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst - Benzinga
Revvity (NYSE:RVTY) Raised to Buy at Bank of America - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Fmr LLC Purchases 45,040 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals? - Yahoo Finance
State Street Corp Acquires 17,832 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity, Inc. (NYSE:RVTY) Shares Sold by First National Bank of Omaha - MarketBeat
Quantinno Capital Management LP Has $5.58 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Trading (RVTY) With Integrated Risk Controls - Stock Traders Daily
Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report? - MSN
Cinctive Capital Management LP Makes New $2.31 Million Investment in Revvity, Inc. (NYSE:RVTY) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 48,700 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Raises Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Verition Fund Management LLC Has $8.41 Million Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Timber Creek Capital Management LLC Acquires 4,336 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Bank of Montreal Can Trims Stock Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
BNP Paribas Financial Markets Trims Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
RVTY (Revvity) EV-to-Revenue : 5.96 (As of Nov. 29, 2024) - GuruFocus.com
Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More - Yahoo Finance
Revvity, Inc. (NYSE:RVTY) Shares Sold by Citigroup Inc. - MarketBeat
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
자본화:
|
볼륨(24시간):